{"DataElement":{"publicId":"2459563","version":"1","preferredName":"Carcinoid Tumor Histologic Category","preferredDefinition":"the histologic category of carcinoid tumor.","longName":"CARC_HIST_CAT","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2459561","version":"1","preferredName":"Carcinoid Tumor Histologic Classification","preferredDefinition":"information related to the histologic classification or category of a carcinoid tumor, a slow growing neuroendocrine tumor, composed of uniform, round, or polygonal cells having monotonous, centrally located nuclei and small nucleoli, infrequent mitoses, and no necrosis.","longName":"CARC_TUM_HIST_CLASS","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2459559","version":"1","preferredName":"Carcinoid Tumor","preferredDefinition":"Carcinoid tumor, also known as well differentiated endocrine neoplasm, is a slow growing neuroendocrine tumor, composed of uniform, round, or polygonal cells having monotonous, centrally located nuclei and small nucleoli, infrequent mitoses, and no necrosis.  The tumor may show a variety of patterns, such as solid, trabecular, and acinar.  Electron microscopy shows small secretory granules.  Immunohistochemical studies reveal NSE, as well as chromogranin immunoreactivity.  Malignant histology (cellular pleomorphism, hyperchromatic nuclei, prominent nucleoli, necrosis, and mitoses) can occasionally be seen.  Such cases may have an aggressive clinical course.  Gastrointestinal tract and lung are common sites of involvement.","longName":"C2915","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Carcinoid Tumor","conceptCode":"C2915","definition":"A slow growing neuroendocrine tumor, composed of uniform, round, or polygonal cells having monotonous, centrally located nuclei and small nucleoli, infrequent mitoses, and no necrosis.  The tumor may show a variety of patterns, such as solid, trabecular, and acinar.  Electron microscopy shows small secretory granules.  Immunohistochemical studies reveal NSE, as well as chromogranin immunoreactivity.  Malignant histology (cellular pleomorphism, hyperchromatic nuclei, prominent nucleoli, necrosis, and mitoses) can occasionally be seen.  Such cases may have an aggressive clinical course.  Gastrointestinal tract and lung are common sites of involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F0AEBD7-96A7-60D5-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-16","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-03-16","modifiedBy":"ONEDATA","dateModified":"2006-03-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207691","version":"1","preferredName":"Histologic Classification","preferredDefinition":"Of or relating to histology.:Classification; the grouping of things into classes or categories.","longName":"C25526:C25161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-2C90-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F0AEBD7-96A8-60D5-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-16","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-03-16","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2459562","version":"1","preferredName":"Carcinoid Tumor Histologic Category","preferredDefinition":"the histologic classification for carcinoid tumor.","longName":"CARCINOID_HIST_CAT","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"75","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Carcinoid","valueDescription":"Carcinoid tumor","ValueMeaning":{"publicId":"2567910","version":"1","preferredName":"Carcinoid tumor","longName":"2567910","preferredDefinition":"Carcinoid tumor","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Carcinoid Tumor","conceptCode":"C2915","definition":"A slow growing neuroendocrine tumor, composed of uniform, round, or polygonal cells having monotonous, centrally located nuclei and small nucleoli, infrequent mitoses, and no necrosis.  The tumor may show a variety of patterns, such as solid, trabecular, and acinar.  Electron microscopy shows small secretory granules.  Immunohistochemical studies reveal NSE, as well as chromogranin immunoreactivity.  Malignant histology (cellular pleomorphism, hyperchromatic nuclei, prominent nucleoli, necrosis, and mitoses) can occasionally be seen.  Such cases may have an aggressive clinical course.  Gastrointestinal tract and lung are common sites of involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D653-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-02","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F0AEBD7-96D0-60D5-E044-0003BA3F9857","beginDate":"2006-03-16","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-03-16","modifiedBy":"CAMPBELB","dateModified":"2006-03-16","deletedIndicator":"No"},{"value":"Low grade/well-differentiated neuroendocrine carcinoma","valueDescription":"Low grade/well-differentiated neuroendocrine carcinoma","ValueMeaning":{"publicId":"2578330","version":"1","preferredName":"Low grade/well-differentiated neuroendocrine carcinoma","longName":"2578330","preferredDefinition":"Low grade/well-differentiated neuroendocrine carcinoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FF07-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-16","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-03-16","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F1DD83A-2729-192F-E044-0003BA3F9857","beginDate":"2006-03-16","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-03-16","modifiedBy":"ONEDATA","dateModified":"2006-03-16","deletedIndicator":"No"},{"value":"Atypical carcinoma","valueDescription":"atypical carcinoma","ValueMeaning":{"publicId":"2578331","version":"1","preferredName":"atypical carcinoma","longName":"2578331","preferredDefinition":"atypical carcinoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FF08-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-16","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-03-16","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F1DD83A-272D-192F-E044-0003BA3F9857","beginDate":"2006-03-16","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-03-16","modifiedBy":"ALAIS","dateModified":"2007-09-21","deletedIndicator":"No"},{"value":"Intermediate grade/moderate-differentiated neuroendocrine carcinoma","valueDescription":"Intermediate grade/moderate-differentiated neuroendocrine carcinoma","ValueMeaning":{"publicId":"2578332","version":"1","preferredName":"Intermediate grade/moderate-differentiated neuroendocrine carcinoma","longName":"2578332","preferredDefinition":"Intermediate grade/moderate-differentiated neuroendocrine carcinoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FF09-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-16","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-03-16","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F1DD83A-2731-192F-E044-0003BA3F9857","beginDate":"2006-03-16","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-03-16","modifiedBy":"ONEDATA","dateModified":"2006-03-16","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2559653","version":"1","preferredName":"Other","longName":"2559653","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B612-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2023-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F1DD83A-2734-192F-E044-0003BA3F9857","beginDate":"2006-03-16","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-03-16","modifiedBy":"ONEDATA","dateModified":"2006-03-16","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2433877","version":"1","preferredName":"Category","preferredDefinition":"Category; used informally to mean a class of things.","longName":"C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"062E16DD-4D2F-16F1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-28","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-28","modifiedBy":"ONEDATA","dateModified":"2005-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F0AEBD7-96BA-60D5-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-16","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-03-16","modifiedBy":"MAESKEB","dateModified":"2009-05-06","changeDescription":"Lung Change Management 09/07","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"CARC_HIST_CAT","type":"USED_BY","context":"Alliance"}],"ReferenceDocuments":[{"name":"Type of disease","type":"Preferred Question Text","description":"Type of disease","url":null,"context":"CTEP"}],"origin":"SWOG CRF:Southwest Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F1DB689-0360-1CA7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-16","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-03-16","modifiedBy":"FORMBUILDER","dateModified":"2014-07-25","changeDescription":"Lung Change Management 09/07","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}